International Clinical Trial: Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215026) titled 'Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes' on Oct. 8.

Study Type: Observational

Primary Sponsor: AstraZeneca

Condition: Non-small Cell Lung Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: October 31, 2025

Target Sample Size: 800

To know more, visit https://clinicaltrials.gov/study/NCT07215026

Published by HT Digital Content Services with permission from Health Daily Digest....